KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Cash from Investing Activities: 2010-2022

Historic Cash from Investing Activities for TherapeuticsMD (TXMD) over the last 13 years, with Dec 2022 value amounting to -$355,000.

  • TherapeuticsMD's Cash from Investing Activities rose 95.11% to -$74,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$355,000, marking a year-over-year increase of 84.03%. This contributed to the annual value of -$355,000 for FY2022, which is 84.03% up from last year.
  • Latest data reveals that TherapeuticsMD reported Cash from Investing Activities of -$355,000 as of FY2022, which was up 84.03% from -$2.2 million recorded in FY2021.
  • TherapeuticsMD's 5-year Cash from Investing Activities high stood at -$355,000 for FY2022, and its period low was -$23.9 million during FY2019.
  • For the 3-year period, TherapeuticsMD's Cash from Investing Activities averaged around -$1.4 million, with its median value being -$1.6 million (2020).
  • In the last 5 years, TherapeuticsMD's Cash from Investing Activities slumped by 2,499.16% in 2018 and then skyrocketed by 93.31% in 2020.
  • Over the past 5 years, TherapeuticsMD's Cash from Investing Activities (Yearly) stood at -$21.5 million in 2018, then dropped by 11.14% to -$23.9 million in 2019, then skyrocketed by 93.31% to -$1.6 million in 2020, then slumped by 39.11% to -$2.2 million in 2021, then soared by 84.03% to -$355,000 in 2022.